Towards better process understanding: Chemometrics and multivariate measurements in manufacturing of solid dosage forms

Journal of Pharmaceutical Sciences

Volumn 102, Issue 5, 2013, Pages 1385-1403

  Matero, Sanni ^a,b   Den Berg, Frans van ^a   Poutiainen, Sami ^c   Rantanen, Jukka ^b   Pajander, Jari ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Chemometrics; Granulation; Mixing; Multivariate data analysis; Solid dosage form; Tablet; Unit operations

Indexed keywords

ATTENUATED TOTAL REFLECTION; BOOTSTRAPPING; CHEMOMETRICS; CLASSIFICATION; CONTROL STRATEGY; DATA ANALYSIS; DISCRIMINANT ANALYSIS; DRUG DOSAGE FORM; DRUG GRANULATION; DRUG INDUSTRY; DRUG MANUFACTURE; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC RADIATION; FACTORIAL ANALYSIS; FOOD AND DRUG ADMINISTRATION; IMAGE ANALYSIS; INFORMATION PROCESSING; INFORMATION SYSTEM; MULTIPLE LINEAR REGRESSION ANALYSIS; PARALLEL FACTOR ANALYSIS; PARTIAL LEAST SQUARES REGRESSION; POWDER; POWDER MIXING; PROCESS ANALYTICAL TECHNOLOGY; PROCESS CONTROL; PROCESS MONITORING; PROCESS TECHNOLOGY; QUALITY CONTROL; RAMAN SPECTROMETRY; REVIEW; SOFT INDEPENDENT MODELLING OF CLASS ANALOGY; SOLID DOSAGE FORM; SOUND; SPECTROSCOPY; TABLET MANUFACTURE; TERAHERTZ SPECTROSCOPY;

EID: 84876335478     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23472     Document Type: Review

References (227)

1. Rudnic EM, Kottke MK. 1996. Tablet dosage forms. In Modern pharmaceutics, 3rd ed., revised and expanded; Banker GS, Rhodes CT, Eds. New York: Marcel Dekker, pp 333-394.
2. Venkatraman S, Davar N, Chester A, Kleiner L. 2000. An overview of controlled release systems. In Handbook of pharmaceutical controlled release technology; Wise DL, Ed. New York: Marcel Dekker Inc., pp 431-463.
3. Kourti T. 2006. Process analytical technology beyond real-time analyzers: The role of multivariate analysis. Crit Rev Anal Chem 36:257-278.
4. Sandell D, Vukovinsky K, Diener M, Hofer J, Pazdan J, Timmermans J. 2006. Development of a content uniformity test suitable for large sample sizes. Drug Inf J 40:337-344.
5. Gabrielsson J, Lindberg NO, Lundstedt T. 2002. Multivariate methods in pharmaceutical applications. J Chemometr 16:141-160.
6. Morris KR, Nail SL Peck GE, Byrn, SR, Griesser UJ, Stowell JG, Hwang SJ, Park K. 1998. Advances in pharmaceutical materials and processing. Pharm Sci Technol Today 1:235-245.
7. Balboni ML. 2003. Process analytical technology: Concepts and principles. Pharm Technol October: 54-67.
8. Yu LX. 2008. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharm Res 25:781-791.
9. Wold S, Cheney J, Kettaneh N, McCready C. 2006. The chemometric analysis of point and dynamic data in pharmaceutical and biotech production (PAT)-some objectives and approaches. Chemometr Intell Lab Syst 84:159-163.
10. Rajalahti T, Kvalheim OM. 2011. Multivariate data analysis in pharmaceutics: A tutorial review. Int J Pharm 417:280-290.
11. Reich G. 2005. Near-infrared spectroscopy and imaging: Basic principles and pharmaceutical applications. Adv Drug Deliver Rev 57:1109-1143.
12. Gendrin C, Roggo Y, Collet C. 2008. Pharmaceutical applications of vibrational chemical imaging and chemometrics: A review. J Pharm Biomed Anal 48:533-553.
13. Scott P. 2009. Process analytical technology: Applications to the pharmaceutical industry. Dissolution Technol 9:6-9.
14. Munson J, Stanfield CF, Gujral B. 2006. A review of process analytical technology (PAT) in the US pharmaceutical industry. Curr Pharm Anal 2:405-414.
15. Workman J Jr, Lavine B, Chrisman R, Koch M. 2011. Process analytical chemistry. Anal Chem 83:4557-4578.
16. Callis JB, Illman DL, Kowalski BR. 1987. Process analytical-chemistry. Anal Chem 59:A624-A637.
17. McLennan F, Kowalski BR, Eds. 1995. Process analytical chemistry. London: Blackie Academic & Professional.
18. Hardy IJ, Cook WG. 2003. Predictive and correlative techniques for the design, optimisation and manufacture of solid dosage forms. J Pharm Pharmacol 55:3-18.
19. Miller CE. 2005. Chemometrics in process analytical chemistry. In Process analytical technology: Spectroscopic tools and implementation strategies for the chemical and pharmaceutical industries; Bakeev KA, Ed. Blackwell Publishing Ltd., Oxford, pp 226-328.
20. Kourti T. 2006. The process analytical technology initiative and multivariate process analysis, monitoring and control. Anal Bioanal Chem 384:1043-1048.
21. Cogdill, RP, Anderson CA, Delgado-Lopez M, Molseed D, Chisholm R, Bolton R, Herkert T, Afnan AM, Drennen JK. 2005. Process analytical technology case study part I: Feasibility studies for quantitative near-infrared method development. AAPS Pharm Sci Tech 6:262-272.
22. Skoog DA. 1985. Principles of instrumental analysis. 3rd ed. Harcourt Brace: Saunders College, Philadelphia, USA.
23. Luypaert J, Massart DL, Heyden YV. 2007. Near-infrared spectroscopy applications in pharmaceutical analysis. Talanta 72:865-883.
24. Roggo Y, Chalus P, Maurer L, Lema-Martinez C, Edmond A, Jent N. 2007. A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies. J Pharm Biomed Anal 44:683-700.
25. Roggo Y, Jent N, Edmond A, Chalus P, Ulmschneider M. 2007. Characterizing process effects on pharmaceutical solid forms using near-infrared spectroscopy and infrared imaging. Eur J Pharm Biopharm 61:100-110.
26. Rantanen J. 2007. Process analytical applications of Raman spectroscopy. J Pharm Pharmacol 59:171-177.
27. McGoverin CM, Rades T, Gordon KC. 2008. Recent pharmaceutical applications of Raman and terahertz spectroscopies. J Pharm Sci 97:4598-4621.
28. Sasic S. 2007. Raman mapping of low-content API pharmaceutical formulations. I. Mapping of Alprazolam in Alprazolam/Xanax tablets. Pharm Res 24:58-65.
29. Rinnan Å, van den Berg F, Engelsen SB. 2009. Review of the most common pre-processing techniques for near-infrared spectra. TrAC Trend Anal Chem 28:1201-1222.
30. Matero S, Poutiainen S, Leskinen J, Hakulinen M, Lahtela-Kakkonen M, Ketolainen J, Lappalainen R, Reinikainen S-P, Järvinen K, Poso A. 2009. Acoustic emission usability in monitoring of fluidized bed granulation. Chemometr Intell Lab 97:75-81.
31. Matero S, Poutiainen S, Leskinen J, Jarvinen K, Ketolainen J, Poso A, Reinikainen S-P. 2010. Estimation of granule size distribution for batch fluidized bed granulation process using acoustic emission and N-way PLS. J Chemometr 24:464-471.
32. Geladi P Esbensen K. 1990. The start and early history of chemometrics: Selected interviews. Part 1. J Chemometr 4:337-354.
33. Esbensen K, Geladi P. 1990. The start and early history of chemometrics: Selected interviews. Part 2. J Chemometr 4:389-412.
34. Workman J. 2002. The state of multivariate thinking for scientists in industry: 1980-2000. Chemometr Intell Lab 60:13-23.
35. Martens H, Martens M. 2001. Multivariate analysis of quality: An introduction. Chichester, UK: Wiley
36. Kourti T, Nomikos P, MacGregor JF. 1995. Analysis, monitoring and fault diagnosis of batch process using multiblock and multiway PLS. J Proc Cont 5:277-284.
37. Bro R. 2003. Multivariate calibration: What is in chemometrics for the analytical chemist? Anal Chim Acta 500:185-194.
38. Wold S, Esbensen K, Geladi P. 1987. Principal component analysis. Chemometr Intell Lab 2:37-52.
39. Garcia-Muñoz S, Kourti T, MacGregor JF, Mateos AG, Murphy G. 2003. Troubleshooting of an industrial batch process using multivariate methods. Ind Eng Chem Res 42:3592-3601.
40. Chiang LH, Colegrove LF. 2007. Industrial implementation of on-line multivariate quality control. Chemometr Intell Lab 88:143-153.
41. Wise BM, Gallagher NB. 1996. The process chemometrics approach to process monitoring and fault detection. J Process Contr 6:329-348.
42. Bro R. 1997. PARAFAC. Tutorial and applications. Chemometr Intell Lab 38:149-171.
43. Bro R. 1998. Multi-way analysis in the food industry. Doctoral dissertation. Amsterdam, the Netherlands: University of Amsterdam.
44. Rodriguez-Rodriguez C, Amigo MJ, Coello J, Maspoch S. 2007. An introduction to multivariate curve resolution-alternating least squares: spectrophotometric study of the acid-base equilibria of 8-hydroxyquinoline-5-sulfonic acid. J Chem Educ 84:1190-1192.
45. Wold S, Sjöström M, Eriksson L. 2001. PLS-regression: A basic tool of chemometrics. Chemometr Intell Lab 58:109-130.
46. Brereton RG. 2003. Chemometrics: Data analysis for the laboratory and chemical plant. West Sussex, UK: Wiley
47. Brereton RG. 2007. Applied chemometrics for scientists. West Sussex, UK: Wiley
48. Doherty SJ, Kettler CN. 2005. On-line applications in the pharmaceutical industry. In Process analytical technology: Spectroscopic tools and implementation strategies for the chemical and pharmaceutical industries; Bakeev KA, Ed. Oxford, UK:Blackwell, pp 329-361.
49. Skibsted ETS, Westerhuis JA, Smilde AK, Witte DT. 2007. Examples of NIR based real time release in tablet manufacturing. J Pharm Biomed 43:1297-1305.
50. Muzzio FJ, Robinson P, Wightman C, Brone, D. 1997. Sampling practices in powder blending. Int J Pharm 155:153-178.
51. Tsujimoto H, Yokoyama T, Huang CC, Sekiguchi I. 2000. Monitoring particle fluidization in a fluidized bed granulator with an acoustic sensor. Powder Technol 113:88-96.
52. Iveson SM, Litster JD, Hapgood K, Ennis BJ. 2001. Nucleation, growth and breakage phenomena in agitated wet granulation processes: A review. Powder Technol 117:3-39.
53. Litster JD. 2003. Scaleup of wet granulation processes: Science not art. Powder Technol 130:35-40.
54. Wu H, Khan MA, Hussain AS. 2007. Process control perspective for process analytical technology: Integration of chemical engineering practice into semiconductor and pharmaceutical industries. Chem Eng Commun 194:760-779.
55. Westerhuis JA, Coenegracht PMJ, Lerk CF. 1997. Multivariate modelling of the tablet manufacturing process with wet granulation for tablet optimization and in-process control. Int J Pharm 156:109-117.
56. Jørgensen AC, Rantanen J, Luukkonen, P, Laine S, Yliruusi J. 2004. Visualization of a pharmaceutical unit operation: Wet granulation. Anal Chem 76:5331-5338.
57. Tabasi SH, Fahmy R, Bensley D, O'Brien C, Hoag SW. 2008. Quality by design, part I: Application of NIR spectroscopy to monitor tablet manufacturing process. J Pharm Sci 97:4040-4051.
58. Lionberger RA, Lee SL, Lee LM, Raw A, Yu LX. 2008. Quality by design: Concepts for ANDAs. AAPS J 10:268-276.
59. Matero S, Poutiainen S, Leskinen J, Reinikainen S-P, Ketolainen J, Järvinen K, Poso A. 2009. Monitoring of wetting phase of fluidized bed granulation process using multi-way methods: The separation successful from unsuccessful batches. Chemometr Intell Lab 96:88-93.
60. Burggraeve A, Van den Kerkhof T, Hellings M, Remon JP, Vervaet C, De Beer T. 2011. Batch statistical process control of a fluid bed granulation process using in-line spatial filter velocimetry and product temperature measurements. Eur J Pharm Sci 42:584-592.
61. Skibsted E. 2005. PAT and beyond. Doctoral dissertation. Amsterdam, the Netherlands: University of Amsterdam.
62. Polizzi MA, Garcia-Munoz S. 2011. A framework for in-silico formulation design using multivariate latent variable regression methods. Int J Pharm 418:235-242.
63. Rathore AS, Saleki-Gerhardt A, Montgomery SH, Tyler SM. 2009. Quality by Design: Industrial case studies on defining and implementing design space for pharmaceutical processes (Part 2). Biopharm Int, January 22:36.
64. Bogomolov A. 2011. Multivariate process trajectories: Capture, resolution and analysis. Chemometr Intell Lab 108:49-63.
65. Matero S, Reinikainen S-P, Lahtela-Kakkonen M, Korhonen O, Ketolainen J, Poso A. 2008. Estimation of drug release profiles of heterogeneous drugs from starch acetate matrix tablet using molecular descriptors. J Chemometr 22:653-660.
66. Kourti T. 2009. Quality by design in the pharmaceutical industry: The role of multivariate analysis. Am Pharm Rev 12:118-123.
67. Huang J, Kaul G, Cai C, Chatlapalli R, Hernandez-Abad P, Ghosh K, Nagi A. 2009. Quality by design case study: An integrated multivariate approach to drug product and process development. Int J Pharm 382:23-32.
68. Aaltonen J, Alleso M, Mirza S, Koradia V, Gordon KC, Rantanen J. 2009. Solid form screening-a review. Eur J Pharm Biopharm 71:23-37.
69. Chieng N, Rades T, Aaltonen J. 2011. An overview of recent studies on the analysis of pharmaceutical polymorphs. J Pharm Biomed Anal 55:618-644.
70. Staniforth JN. 1987. Order out of chaos. J Pharm Pharmacol 39:329-334.
71. Davies P. 2001. Oral solid dosage forms. In Pharmaceutical preformulation and formulation: A practical guide from candidate drug selection to commercial dosage form; Gibson M, Ed. New York: Taylor and Francis, pp 379-458.
72. Venables HJ, Wells JI. 2001. Powder mixing. Drug Dev Ind Pharm 27:599-612.
73. Twitchell AM. 2007. Mixing. In Aulton's pharmaceutics: The design and manufacture of medicines; Aulton ME, Ed. Philadelphia: Elsevier Ltd, pp 152-167.
74. Nyström C, Karehill PG. 1996. The importance of intermolecular bonding forces and the concept of bonding surface area. In Pharmaceutical powder compaction technology; Alderborn G, Nyström C, Eds. New York: Marcel Dekker, Inc., pp 17-53.
75. Barra J, Falson-Rieg F, Doelker E. 1999. Influence of the organization of binary mixes on their compactibility. Pharm Res 16:1449-1455.
76. van Veen B, Pajander J, Zuurman K, Lappalainen R, Poso A, Frijlink HW, Ketolainen J. 2005. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets. Eur J Pharm Biopharm 61:149-157.
77. Pajander J, Korhonen O, Laamanen M, Ryynänen EL, Grimsey I, van Veen B, Ketolainen J. 2009. Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets. J Pharm Sci 98:3676-3690.
78. Brone D, Wightman C, Connor K, Alexander A, Muzzio FJ, Robinson P. 1997. Using flow perturbations to enhance mixing of dry powder in V-blenders. Powder Technol 91:165-172.
79. Chibwana C, Moys MH. 2006. Radial mixing of particles in a dry batch ball mill. Powder Technol 163:139-144.
80. Kale K, Hapgood K, Stewart P. 2009. Drug agglomeration and dissolution-what is the influence of powder mixing? Eur J Pharm Biopharm 72:156-164.
81. Marigo M, Cairns DL, Davies M, Ingram A, Stitt EH. 2012. A numerical comparison of mixing efficiencies of solids in a cylindrical vessel subject to a range of motions. Powder Technol 217:540-547.
82. Bridgewater J. 1976. Fundamental powder mixing mechanisms. Powder Technol 15:215-236.
83. Führer C. 1996. Interparticulate attraction mechanisms. In Pharmaceutical powder compaction technology; Alderborn G, Nyström C, Eds. New York: Marcel Dekker, Inc., pp 1-15.
84. Zeng XM, Martin GP, Marriot C. 2001. Interparticulate forces. In Particulate interactions in dry powder formulations for inhalation; Zeng XM, Martin GP, Marriot C, Eds. New York: Taylor & Francis, pp 1-28.
85. Podczeck F, Newton JM, James MB. 1997. Variations in the adhesion force between a drug and carrier particles as a result of changes in the relative humidity of the air. Int J Pharm 149:151-160.
86. Barra J, Lescure F, Falson-Rieg F, Doelker R. 1998. Can the organization of a binary mix be predicted from the surface energy, cohesion parameter and particle size of its components? Pharm Res 15:1727-1736.
87. Nikolakakis I, Newton JM, Malamataris S. 2002. Solid state 'adsorption' of fine antibiotic powders onto sorbitol: Effects of particle size, state of sorbed water and surface free energy characteristics. Eur J Pharm Sci 17:229-238.
88. Mäki R, Suihko E, Rost S, Heiskanen M, Murtomaa M, Lehto VP, Ketolainen J. 2007. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration. J Pharm Sci 96:438-447.
89. Wong LW, Pilpel N. 1990. Effect of particle shape on the mixing of powders. J Pharm Pharmacol 42:1-6.
90. Swaminathan V, Kildsig DO. 2000. The effect of particle morphology on the physical stability of pharmaceutical powder mixtures: The effect of surface roughness of the carrier on the stability of ordered mixtures. Drug Dev Ind Pharm 26:365-373.
91. Grimsey IM, Feeley JC, York P. 2002. Analysis of the surface energy of pharmaceutical powders by inverse gas chromatography. J Pharm Sci 91:571-583.
92. Wadke DA, Jacobson H. 1980. Preformulation testing. In Pharmaceutical dosage forms: Tablets; Lieberman HA, Lachman L, Eds. New York: Marcel Dekker, Inc., pp 1-59.
93. Staniforth JN. 1981. Total mixing. Int J Pharm Tech Prod Manuf 2:7-12.
94. Bellamy LJ, Nordon A, Littlejohn D. 2008. Effects of particle size and cohesive properties on mixing studied by non-contact NIR. Int J Pharm 361:87-91.
95. Bittner LKH, Heigl N, Petter CH, Noisternig MF, Griesser UJ, Bonn GK, Huck CW. 2011. Near-infrared reflection spectroscopy (NIRS) as a succesful tool for simultaneous identification and particle size determination of amoxicillin trihydrate. J Pharm Biomed Anal 54:1059-1064.
96. Muzzio FJ, Goodridge C, Alexander A, Arratia P, Yang H, Sudah O, Mergen G. 2003. Sampling and characterization of pharmaceutical powders and granular blends. Int J Pharm 250:51-64.
97. Wargo DJ, Drennen JK. 1996. Near-infrared spectroscopic characterization of pharmaceutical powder blends. J Pharm Biomed Anal 14:1415-1423.
98. Lai C, Holt D, Leung J, Cooney C, Raju G, Hansen P. 2001. Real time and noninvasive monitoring of dry powder blend homogeneity. AIChE J 47:2618-2622.
99. Skibsted ETS, Boelens HFM, Westerhuis JA, Witte DT, Smilde AK. 2006. Simple assessment of homogeneity in pharmaceutical mixing processes using a near-infrared reflectance probe and control charts. J Pharm Biomed Anal 41:26-35.
100. El-Hagrasy AS, D'Amico F, Drennen JK. 2006. A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation. J Pharm Sci 95:392-406.
101. Berntsson O, Danielsson LG, Lagerholm B, Folestad S. 2002. Quantitative in-line monitoring of powder blending by near infrared reflection spectroscopy. Powder Technol 123:185-193.
102. De Beer TRM, Bodson C, Dejaegher B, Walczak B, Vercruysse P, Burggraeve A, Lemos A, Delattre L, Heyden YV, Remon JP, Vervaete C, Baeyens WRG. 2008. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process. J Pharm Biomed Anal 48:772-779.
103. Amigo JM, Cruz J, Bautista M, Maspoch S, Coello J, Blanco M. 2008. Study of pharmaceutical samples by NIR chemical-image and multivariate analysis. TRAC-Trend Anal Chem 27:696-713.
104. Sekulic SS, Wakeman J, Doherty P, Hailey PA. 1998. Automated system for the on-line monitoring of powder blending processes using near-infrared spectroscopy. Part II. Qualitative approaches to blend evaluation. J Pharm Biomed Anal 17:1285-1309.
105. El-Hagrasy AS, Morris HR, D'Amico F, Lodder RA, Drennen JK. 2001. Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity. J Pharm Sci 90:1298-1307.
106. Rantanen J, Wikstrom H, Turner R, Taylor LS. 2005. Use of in-line near-infrared spectroscopy in combination with chemometrics for improved understanding of pharmaceutical processes. Anal Chem 77:556-563.
107. El-Hagrasy AS, Drennen JK. 2006. A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part III: Quantitative near-infrared calibration for prediction of blend homogeneity and characterization of powder mixing kinetics. J Pharm Sci 95:422-434.
108. Shi Z, Cogdill RP, Short SM, Anderson CA. 2008. Process characterization of powder blending by near-infrared spectroscopy: Blend end-points and beyond. J Pharm Biomed Anal 47:738-745.
109. Sulub Y, Wabuyele B, Gargiulo P, Pazdan J, Cheney J, Berry J, Gupta A, Shah R, Wu H, Khan M. 2009. Real-time on-line blend uniformity monitoring using near-infrared reflectance spectrometry: A noninvasive off-line calibration approach. J Pharm Biomed Anal 49:48-54.
110. Puchert T, Holzhauer C-V, Menezes JC, Lochmann D, Reich G. 2011. A new PAT/QbD approach for the determination of blend homogeneity: Combination of on-line NIRS analysis with PC Scores Distance Analysis (PC-SDA). Eur J Pharm Biopharm 78:173-182.
111. Ma H, Anderson CA. 2008. Characterization of pharmaceutical powder blends by NIR chemical imaging. J Pharm Sci 97:3305-3320.
112. El-Hagrasy AS, Delgado-Lopez M, Drennen JK. 2006. A process analytical technology approach to near-infrared process control of pharmaceutical powder blending: Part II: Qualitative near-infrared models for prediction of blend homogeneity. J Pharm Sci 95:407-421.
113. Gowen AA, O'Donnell CP, Cullen PJ, Bell SEJ. 2008. Recent applications of chemical imaging to pharmaceutical process monitoring and quality control. Eur J Pharm Biopharm 69:10-22.
114. Amigo JM. 2010. Practical issues of hyperspectral imaging analysis of solid dosage forms. Anal Bioanal Chem 398:93-109.
115. Amigo JM, Ravn C. 2009. Direct quantification and distribution assessment of major and minor components in pharmaceutical tablets by NIR-chemical imaging. Eur J Pharm Sci 37:76-82.
116. De Beer T, Burggraeve A, Fonteyne M, Saerens L, Remon JP, Vervaet C. 2011. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes. Int J Pharm 417:32-47.
117. Kristensen HG, Schaefer T. 1987. Granulation: A review of pharmaceutical wet- granulation. Drug Dev Ind Pharm 13:803-872.
118. Faure A, York P, Rowe RC. 2001. Process control and scale-up of pharmaceutical wet granulation processes: A review. Eur J Pharm Biopharm 52:269-277.
119. Hemati A, Cherif R, Saleh K, Pont V. 2003. Fluidized bed coating and granulation: Influence of process-related variables and physicochemical properties on the growth kinetics. Powder Technol 130:18-34.
120. Lee TH, Lin SY. 2004. Microspectroscopic FT-IR mapping system as a tool to assess blend homogeneity of drug-excipient mixtures. Eur J Pharm Sci 23:117-122.
121. Keary CM, Sheskey PJ. 2004. Preliminary report on the discovery of a new pharmaceutical granulation process using foamed aqueous binders. Drug Dev Ind Pharm 30:831-845.
122. Schaefer T, Holm P, Kristensen HG. 1990. Melt granulation in a laboratory scale high shear mixer. Drug Dev Ind Pharm 16:1249-1277.
123. Royce A, Suryawanshi J, Shah U, Vishnupad K. 1996. Alternative granulation technique: Melt granulation. Drug Dev Ind Pharm 22:917-924.
124. Thies R, Klenidebudde P. 1999. Melt pelletisation of a hygroscopic drug in a high shear mixer. Part 1. Influence of process variables. Int J Pharm 188:131-143.
125. Gao JZH, Jain A, Motheram R, Gray DB, Hussain MA. 2002. Fluid bed granulation of a poorly water soluble, low density, micronized drug: comparison with high shear granulation. Int J Pharm 237:1-14.
126. Fung KY, Ng KM Nakajima S, Wibowo C. 2006. A systematic iterative procedure for determining granulator operating parameters. AIChE J 52:3189-3202.
127. Watano S, Sato Y, Miyanami K. 1997. Application of a neural network to granulation scale-up. Powder Technol 90:153-159.
128. Hegedus A, Pintye-Hódi K. 2007. Influence of the type of the high-shear granulator on the physico-chemical properties of granules. Chem Eng Process 46:1012-1019.
129. Knight P. 2004. Challenges in granulation technology. Powder Technol 140:156-162.
130. Thielmann F, Naderi M, Ansari MA, Stepanek F. 2008. The effect of primary particle surface energy on agglomeration rate in fluidised bed wet granulation. Powder Technol 181:160-168.
131. Poutiainen S, Pajander J, Savolainen A, Ketolainen J, Jarvinen, K. 2011. Evolution of granule structure and drug content during fluidized bed granulation by x-ray microtomography and confocal raman spectroscopy. J Pharm Sci 100:5254-5269.
132. Holm P, Schaefer T, Kristensen HG. 1985. Granulation in high-speed mixers. Part 5. Power consumption and temperature changes during granulation. Powder Technol 43:213-223.
133. Watano S, Terashita K, Miyanami K. 1991. Determination of end-point with a complex granulation applying infrared moisture sensor. Chem Pharm Bull 39:1013-1017.
134. Watano S, Terashita K, Miyanami K. 1995. Method for process monitoring and determination of operational end-point by frequency-analysis of power-consumption in agitation granulation. Adv Powder Technol 6:91-102.
135. Knight P, Johansen A, Kristensen HG, Schaefer T, Seville JPK. 2000. An investigation of the effects on agglomeration of changing the speed of a mechanical mixer. Powder Technol 110:204-209.
136. Luukkonen P, Fransson M, Bjorn IN, Hautala J, Lagerholm B, Folestad S. 2008. Real-time assessment of granule and tablet properties using in-line data from a high-shear granulation process. J Pharm Sci 97:950-959.
137. Hapgood KP, Litster JD. 2011. Wet granulation processes. In Chemical engineering in the pharmaceutical industry: R&D to manufacturing; Am Ende DJ, Ed. Hoboken: John Wiley & Sons, pp 757-780.
138. Lipsanen T, Antikainen O, Räikkönen H, Airaksinen S, Yliruusi J. 2007. Novel description of a design space for fluidised bed granulation. Int J Pharm 345:101-107.
139. Hagsten A, Larsen CC, Sonnergaard JM, Rantanen J, Hovgaard L. 2008. Identifying sources of batch to batch variation in processability. Powder Technol 183:213-219.
140. Rimpilainen V, Poutiainen S, Heikkinen LM, Savolainen T, Vauhkonen M, Ketolainen J. 2011. Electrical capacitance tomography as a monitoring tool for high-shear mixing and granulation. Chem Eng Sci 66:4090-4100.
141. Rantanen JT, Laine SJ, Antikainen OK, Mannermaa JP, Simula OE, Yliruusi JK. 2001. Visualization of fluid-bed granulation with self-organizing maps. J Pharm Biomed Anal 24:343-352.
142. Rantanen, J, Rasanen E, Antikainen O, Mannermaa JP, Yliruusi J. 2001. In-line moisture measurement during granulation with a four-wavelength near-infrared sensor: An evaluation of process-related variables and a development of non-linear calibration model. Chemometr Intell Lab 56:51-58.
143. Alcala M, Blanco M, Bautista M, Gonzalez JM. 2010. On-line monitoring of a granulation process by NIR spectroscopy. J Pharm Sci 99:336-345.
144. Muteki K, Swaminathan V, Sekulic SS, Reid GL. 2011. De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies. AAPS PharmSciTech 12:1324-1334.
145. Laitinen N, Rantanen J, Laine S, Antikainen O, Rasanen E, Airaksinen S, Yliruusi J. 2002. Visualization of particle size and shape distributions using self-organizing maps. Chemometr Intell Lab 62:47-60.
146. Laitinen N, Antikainen O, Rantanen J, Yliruusi J. 2004. New perspectives for visual characterization of pharmaceutical solids. J Pharm Sci 93:165-176.
147. Whitaker M, Baker GR, Westrup J, Goulding PA, Rudd DR, Belchamber RM, Collins MP. 2000. Application of acoustic emission to the monitoring and end point determination of a high shear granulation process. Int J Pharm 205:79-91.
148. Papp MK, Pujara CP, Pinal R. 2008. Monitoring of high-shear granulation using acoustic emission: Predicting granule properties. J Pharm Innov 3:113-122.
149. Hansuld EM, Briens L, McCann JAB, Sayani A. 2009. Audible acoustics in high-shear wet granulation: Application of frequency filtering. Int J Pharm 378:37-44.
150. Petrovic J, Chansanroj K, Meier B, Ibric S, Betz G. 2011. Analysis of fluidized bed granulation process using conventional and novel modeling techniques. Eur J Pharm Sci 44:227-234.
151. Poutiainen S, Matero S, Hamalainen T, Leskinen J, Ketolainen J, Jarvinen K. 2012. Predicting granule size distribution of fluidized bed granulation process by regime based PLS modeling of acoustic emission data. Powder Technol 228:149-157.
152. Leskinen JTT, Okkonen MAH, Toiviainen MM, Poutiainen S, Tenhunen M, Teppola P, Lappalainen R, Ketolainen J, Jarvinen K. 2010. Labscale fluidized bed granulator instrumented with non-invasive process monitoring devices. Chem Eng J 164:268-274.
153. Abdul S, Poddar SS. 2004. A flexible technology for modified release of drugs: Multi layered tablets. J Control Release 97:393-405.
154. Alderborn G. 2007. Tablets and compaction. In Aulton's pharmaceutics: The design and manufacture of medicines; Aulton ME, Ed. Philadelphia: Elsevier Ltd., pp 441-482.
155. Pajander J. 2009. Prolonged release starch acetate matrix tablets-relationships between formulation and in vitro dissolution studies. Doctoral dissertation. Kuopio, Finland: University of Kuopio.
156. Muñoz-Ruiz A, Wihervaara M, Häkkinen M, Juslin M, Paronen P. 1997. Frictional work in double-sided tablet compression. J Pharm Sci 86:481-486.
157. Busignies V, Leclerc B, Porion P, Evesque P, Couarraze G, Tchoreloff P. 2006. Quantitative measurements of localized density variations in cylindrical tablets using X-ray microtomography. Eur J Pharm Biopharm 64:38-50.
158. Ellison CD, Ennis BJ, Hamad ML, Lyon RC. 2008. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging. J Pharm Biomed Anal 48:1-7.
159. Roberts RJ, Rowe RC. 1985. The effect of punch velocity on the compaction of a variety of materials. J Pharm Pharmacol 37:377-384.
160. Roberts RJ, Rowe RC. 1986. The effect of the relationship between punch velocity and particle size on the compaction behaviour of materials with varying deformation mechanisms. J Pharm Pharmacol 38:567-571.
161. Marshall PV, York P, Maclaine JQ. 1993. An investigation of the effect of the punch velocity on the compaction properties of ibuprofein. Powder Technol 74:171-177.
162. Katikaneni PR, Upadrashta SM, Rowlings CE, Neau SH, Hileman GA. 1995. Consolidation of ethylcellulose: Effect of particle size, press speed, and lubricants. Int J Pharm 117:13-21.
163. Sinka IC, Motazedian F, Cocks ACF, Pitt KG. 2009. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol 189: 276-284.
164. Steendam R, Frijlink HW, Lerk CF. 2001. Plasticisation of amylodextrin by moisture. Consenquences for compaction behaviour and tablet properties. Eur J Pharm Sci 14:245-254.
165. Alderborn G. 1996. Particle dimensions. In Pharmaceutical powder compaction technology; Alderborn G, Nyström C, Eds. New York: Marcel Dekker, Inc., pp 245-282.
166. Li Q, Rudolph V, Weigl B, Earl A. 2004. Interparticle van der Waals force in powder flowability and compactibility. Int J Pharm 280:77-93.
167. Haware RV, Tho I, Bauer-Brandl A. 2009. Application of multivariate methods to compression behavior evaluation of directly compressible materials. Eur J Pharm Biopharm 72:148-155.
168. Fukunaka T, Sawaguchi K, Golman B, Shinohara K. 2005. Effect of particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling on cohesiveness. Int J Pharm 94:1004-1012.
169. Sun C, Grant DJ. 2001. Effects of initial particle size on the tableting properties of L-lysine monohydrochloride dihydrate powder. Int J Pharm 215:221-228.
170. Steendam R, Eissens AC, Frijlink HW, Lerk CF. 2000. Plasticisation of amylodextrin by moisture: Consequences for drug release from tablets. Int J Pharm 204:23-33.
171. Sun C, Grant DJ. 2001. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm Res 18:274-280.
172. Feng Y, Grant DJ. 2006. Influence of crystal structure on the compaction properties of n- alkyl 4-hydroxybenzoate esters (parabens). Pharm Res 23:1608-1616.
173. Te Wierik GH, Eissens AC, Bergsma J, Arends-Scholte AW, Lerk CF. 1997. A new generation of starch products as excipient in pharmaceutical tablets. II. High surface area retrograded pregelatinized potato starch products in sustained-release tablets. J Control Release 45:25-33.
174. Fichtner F, Mahlin D, Welch K, Gaisford S, Alderborn G. 2008. Effect of surface energy on powder compactibility. Pharm Res 25:2750-2759.
175. Dürig T, Fassihi R. 1997. Mechanistic evaluation of binary effects of magnesium stearate and talc as dissolution retardants at 85% drug loading in an experimental extended-release formulation. J Pharm Sci 86:1092-1098.
176. Pather SI, Russell I, Syce JA, Neau SH. 1998. Sustained release theophylline tablets by direct compression: Part 1: Formulation and in vitro testing. Int J Pharm 164:1-10.
177. Tho I, Bauer-Brandl A. 2011. Quality by design (QbD) approaches for the compression step of tableting. Expert Opin Drug Deliv 8:1631-1644.
178. Paakkunainen M, Matero S, Ketolainen J, Lahtela-Kakkonen M, Poso A, Reinikainen SP. 2009. Uncertainty in dissolution test of drug release. Chemometr Intell Lab 97:82-90.
179. Gabrielsson J, Sjöström M, Lindberg NO, Pihl AC, Lundstedt T. 2006. Multivariate methods in the development of a new tablet formulation: Excipient mixtures and principal properties. Drug Dev Ind Pharm 32:7-20.
180. Andersson M, Ringberg A, Gustafsson C. 2007. Multivariate methods in tablet formulation suitable for early drug development: Predictive models from a screening design of several linked responses. Chemometr Intell Lab 87:125-130.
181. Haware RV, Tho I, Bauer-Brandl A. 2009. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for alpha-lactose monohydrates. Eur J Pharm Biopharm 73:424-431.
182. Matero S, Lahtela-Kakkonen M, Korhonen O, Ketolainen J, Lappalainen R, Poso A. 2006. Chemical space of orally active compounds. Chemometr Intell Lab 84:134-141.
183. Allesø M, Rantanen J, Aaltonen, J, Cornett C, van den Berg F. 2008. Solvent subset selection for polymorph screening. J Chemometr 22:621-631.
184. Korhonen O, Matero S, Poso A, Ketolainen J. 2005. Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets. J Pharm Sci 94:2716-2730.
185. Suihko E, Forbes RT, Korhonen O, Ketolainen J, Paronen P, Gynther J, Poso A. 2005. Prediction of contact angle for pharmaceutical solids from their molecular structure. J Pharm Sci 94:745-758.
186. Tarvainen M, Sutinen R, Somppi M, Paronen P, Poso A. 2001. Predicting plasticization efficiency from three-dimensional molecular structure of a polymer plasticizer. Pharm Res 18:1760-1766.
187. Huuskonen J, Rantanen J, Livingstone D. 2000. Prediction of aqueous solubility for a diverse set of organic compounds based on atom-type electrotopological state indices. Eur J Med Chem 35:1081-1088.
188. Cruciani G, Pastor M, Guba W. 2000. VolSurf: A new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 11:29-39.
189. Milletti F, Storchi L, Sforna G, Cruciani G. 2007. New and original pK(a) prediction method using grid molecular interaction fields. J Chem Inf Model 47:2172-2181.
190. Matero S, Reinikainen S-P, Ketolainen J, Poso A. 2008. Estimation of compatibility of drug and starch acetate to form a sustainable matrix tablet with a desired drug release profile. In 11th Conference on Chemometrics in Analytical Chemistry, conference proceedings.
191. Sun YC, Peng YX, Chen YX, Shukla AJ. 2003. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev 55:1201-1215.
192. Siepmann J, Siepmann F. 2008. Mathematical modeling of drug delivery. Int J Pharm 364:328-343.
193. Cournoyer A, Simard JS, Cartilier L, Abatzoglou N. 2008. Quality control of multi-component, intact pharmaceutical tablets with three different near-infrared apparatuses. Pharm Dev Technol 13:333-343.
194. Sulub Y, Lo Brutto R, Vivilecchia R, Wabuyele B. 2008. Near-infrared multivariate calibration updating using placebo: A content uniformity determination of pharmaceutical tablets. Vib Spectrosc 46:128-134.
195. Ravn C, Skibsted E, Bro R. 2008. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-Comparing common calibration approaches. J Pharm Biomed Anal 48:554-561.
196. Gordon KC, McGoverin CM. 2011. Raman mapping of pharmaceuticals. Int J Pharm 417:151-162.
197. Matero S, Pajander J, Soikkeli AM, Reinikainen SP, Lahtela-Kakkonen M, Korhonen O, Ketolainen J, Poso A. 2007. Predicting the drug concentration in starch acetate matrix tablets from ATR-FTIR spectra using multi-way methods. Anal Chim Acta 595:190-197.
198. Pajander J, Soikkeli AM, Korhonen O, Forbes RT, Ketolainen J. 2008. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing. J Pharm Sci 97:3367-3378.
199. Wu H, Heilweil EJ, Hussain AS, Khan MA. 2008. Process analytical technology (PAT): Quantification approaches in terahertz spectroscopy for pharmaceutical application. J Pharm Sci 97:970-984.
200. Blanco M, Alcala M, Gonzalez JM, Torrasz E. 2006. A process analytical technology approach based on near infrared spectroscopy: Tablet hardness, content uniformity, and dissolution test measurements of intact tablets. J Pharm Sci 95:2137-2144.
201. Alcala M, Ropero J, Vazquez R, Romanach RJ. 2009. Deconvolution of chemical and physical information from intact tablets NIR spectra: Two- and three-way multivariate calibration strategies for drug quantitation. J Pharm Sci 98:2747-2758.
202. Sarraguca MC, Lopes JA. 2009. Quality control of pharmaceuticals with NIR: From lab to process line. Vib Spectrosc 49:204-210.
203. Chalus P, Roggo Y, Walter S, Ulmschneider M. 2005. Near-infrared determination of active substance content in intact low-dosage tablets. Talanta 66:1294-1302.
204. Alcala M, Leon J, Ropero J, Blanco M, Romanach RJ. 2008. Analysis of low content drug tablets by transmission near infrared spectroscopy: Selection of calibration ranges according to multivariate detection and quantitation limits of PLS models. J Pharm Sci 97:5318-5327.
205. Karande AD, Heng PWS, Liew CV. 2010. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tableting process. Int J Pharm 396:63-74.
206. Johansson J, Pettersson S, Folestad S. 2005. Characterization of different laser irradiation methods for quantitative Raman tablet assessment. J Pharm Biomed Anal 39:510-516.
207. Gendrin C, Roggo Y, Collet C. 2007. Content uniformity of pharmaceutical solid dosage forms by near infrared hyperspectral imaging: A feasibility study. Talanta 73:733-741.
208. Cruz J, Blanco M. 2011. Content uniformity studies in tablets by NIR-CI. J Pharm Biomed Anal 56:408-412.
209. Franch-Lage F, Amigo JM, Skibsted E, Maspoch S, Coello J. 2011. Fast assessment of the surface distribution of API and excipients in tablets using NIR-hyperspectral imaging. Int J Pharm 411:27-35.
210. Zhang L, Henson M, Sekulic S. 2005. Multivariate data analysis for Raman imaging of a model pharmaceutical tablet. Anal Chim Acta 545:262-278.
211. Vajna B, Farkas I, Szabo A, Zsigmond Z, Marosi G. 2010. Raman microscopic evaluation of technology dependent structural differences in tablets containing imipramine model drug. J Pharm Biomed Anal 51:30-38.
212. Gottfries J, Depui H, Fransson M, Jongeneelen M, Josefson M, Langkilde FW, Witte DT. 1996. Vibrational spectrometry for the assessment of active substance in metoprolol tablets: A comparison between transmission and diffuse reflectance near-infrared spectrometry. J Pharm Biomed Anal 14:1495-1503.
213. Morisseau KM, Rhodes CT. 1997. Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing. Pharm Res 14:108-111.
214. Otsuka M, Yamane I. 2006. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics. J Pharm Sci 95:1425-1433.
215. Tatavarti AS, Fahmy R, Wu HQ, Hussain AS, Marnane W, Bensley D, Hollenbeck G, Hoag SW. 2005. Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms. AAPS PharmSciTech 6:E91-E99.
216. Shah RB, Tawakkul MA, Khan MA. 2007. Process analytical technology: Chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets. J Pharm Sci 96:1356-1365.
217. Virtanen S, Antikainen O, Yliruusi J. 2008. Determination of the crushing strength of intact tablets using Raman spectroscopy. Int J Pharm 360:40-46.
218. Otsuka M, Yamane I. 2009. Prediction of tablet properties based on near infrared spectra of raw mixed powders by chemometrics: Scale-up factor of blending and tableting processes. J Pharm Sci 98:4296-4305.
219. Adams E, De Maesschalck R, De Spiegeleer B, Vander Heyden Y, Smeyers-Verbeke J, Massart D. 2001. Evaluation of dissolution profiles using principal component analysis. Int J Pharm 212:41-53.
220. Maggio RM, Castellano PM, Kaufman TS. 2008. A new principal component analysis based approach for testing "similarity" of drug dissolution profiles. Eur J Pharm Sci 34:66-77.
221. Donoso M, Ghaly ES. 2004. Prediction of drug dissolution from tablets using near-infrared diffuse reflectance spectroscopy as a nondestructive method. Pharm Dev Technol 9:247-263.
222. Freitas MP, Sabadin A, Silva LM, Giannotti FM, do Couto DA, Tonhi E, Medeiros RS, Coco GL, Russo VFT, Martins JA. 2005. Prediction of drug dissolution profiles from tablets using NIR diffuse reflectance spectroscopy: A rapid and nondestructive method. J Pharm Biomed Anal 39:17-21.
223. Otsuka M, Tanabe H, Osaki K, Otsuka K, Ozaki Y. 2007. Chemoinformetrical evaluation of dissolution property of indomethacin tablets by near-infrared spectroscopy. J Pharm Sci 96:788-801.
224. Gendre C, Boiret M, Genty M, Chaminade P, Pean JM. 2011. Real-time predictions of drug release and end point detection of a coating operation by in-line near infrared measurements. Int J Pharm 421:237-243.
225. Gray V, Kelly G, Xia M, Butler C, Thomas S, Mayock S. 2009. The science of USP 1 and 2 dissolution: Present challenges and future relevance. Pharm Res 26:1289-1302.
226. Wiberg KH, Hultin UK. 2006. Multivariate chemometric approach to fiber-optic dissolution testing. Anal Chem 78:5076-5085.
227. Matero S. 2010. Chemometric methods in pharmaceutical tablet development and manufacturing unit operations. Doctoral dissertation. Kuopio, Finland: University of Eastern Finland.